BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 33529599)

  • 1. Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes.
    Shah PP; Lv W; Rhoades JH; Poleshko A; Abbey D; Caporizzo MA; Linares-Saldana R; Heffler JG; Sayed N; Thomas D; Wang Q; Stanton LJ; Bedi K; Morley MP; Cappola TP; Owens AT; Margulies KB; Frank DB; Wu JC; Rader DJ; Yang W; Prosser BL; Musunuru K; Jain R
    Cell Stem Cell; 2021 May; 28(5):938-954.e9. PubMed ID: 33529599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
    Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
    Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy.
    Cheedipudi SM; Matkovich SJ; Coarfa C; Hu X; Robertson MJ; Sweet M; Taylor M; Mestroni L; Cleveland J; Willerson JT; Gurha P; Marian AJ
    Circ Res; 2019 Apr; 124(8):1198-1213. PubMed ID: 30739589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
    Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
    Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation analysis reveals epimutation hotspots in patients with dilated cardiomyopathy-associated laminopathies.
    Morival JLP; Widyastuti HP; Nguyen CHH; Zaragoza MV; Downing TL
    Clin Epigenetics; 2021 Jul; 13(1):139. PubMed ID: 34246298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of
    Shah D; Virtanen L; Prajapati C; Kiamehr M; Gullmets J; West G; Kreutzer J; Pekkanen-Mattila M; Heliö T; Kallio P; Taimen P; Aalto-Setälä K
    Cells; 2019 Jun; 8(6):. PubMed ID: 31208058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
    Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
    PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells.
    Lee YK; Lau YM; Cai ZJ; Lai WH; Wong LY; Tse HF; Ng KM; Siu CW
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28754655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy.
    Lee J; Termglinchan V; Diecke S; Itzhaki I; Lam CK; Garg P; Lau E; Greenhaw M; Seeger T; Wu H; Zhang JZ; Chen X; Gil IP; Ameen M; Sallam K; Rhee JW; Churko JM; Chaudhary R; Chour T; Wang PJ; Snyder MP; Chang HY; Karakikes I; Wu JC
    Nature; 2019 Aug; 572(7769):335-340. PubMed ID: 31316208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamin A/C mutations in dilated cardiomyopathy.
    Tesson F; Saj M; Uvaize MM; Nicolas H; Płoski R; Bilińska Z
    Cardiol J; 2014; 21(4):331-42. PubMed ID: 24846508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TEAD1 trapping by the Q353R-Lamin A/C causes dilated cardiomyopathy.
    Yamada S; Ko T; Ito M; Sassa T; Nomura S; Okuma H; Sato M; Imasaki T; Kikkawa S; Zhang B; Yamada T; Seki Y; Fujita K; Katoh M; Kubota M; Hatsuse S; Katagiri M; Hayashi H; Hamano M; Takeda N; Morita H; Takada S; Toyoda M; Uchiyama M; Ikeuchi M; Toyooka K; Umezawa A; Yamanishi Y; Nitta R; Aburatani H; Komuro I
    Sci Adv; 2023 Apr; 9(15):eade7047. PubMed ID: 37058558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice.
    Nikolova V; Leimena C; McMahon AC; Tan JC; Chandar S; Jogia D; Kesteven SH; Michalicek J; Otway R; Verheyen F; Rainer S; Stewart CL; Martin D; Feneley MP; Fatkin D
    J Clin Invest; 2004 Feb; 113(3):357-69. PubMed ID: 14755333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alpha-helix variant p.Arg156Pro in LMNA as a cause of hereditary dilated cardiomyopathy: genetics and bioinfomatics exploration.
    Chang L; Huang R; Chen J; Li G; Shi G; Xu B; Wang L
    BMC Med Genomics; 2023 Oct; 16(1):229. PubMed ID: 37784143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
    Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
    Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LMNA p.R541C mutation causes dilated cardiomyopathy in human and mice.
    Yang L; Sun J; Chen Z; Liu L; Sun Y; Lin J; Hu X; Zhao M; Ma Y; Lu D; Li Y; Guo Y; Dong E
    Int J Cardiol; 2022 Sep; 363():149-158. PubMed ID: 35714719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of lamin A/C mutation premature cardiac aging using patient‐specific induced pluripotent stem cells.
    Siu CW; Lee YK; Ho JC; Lai WH; Chan YC; Ng KM; Wong LY; Au KW; Lau YM; Zhang J; Lay KW; Colman A; Tse HF
    Aging (Albany NY); 2012 Nov; 4(11):803-822. PubMed ID: 23362510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating
    Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639
    [No Abstract]   [Full Text] [Related]  

  • 18. Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction.
    Del Monte-Monge A; Ruiz-Polo de Lara Í; Gonzalo P; Espinós-Estévez C; González-Amor M; de la Fuente-Pérez M; Andrés-Manzano MJ; Fanjul V; Gimeno JR; Barriales-Villa R; Dorado B; Andrés V
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
    Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in animal and human pluripotent stem cell modeling of cardiac laminopathy.
    Lee YK; Jiang Y; Ran XR; Lau YM; Ng KM; Lai WH; Siu CW; Tse HF
    Stem Cell Res Ther; 2016 Sep; 7(1):139. PubMed ID: 27649756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.